Jane Street’s Emmaus Life Sciences, Inc. Common Stock EMMA Stock Holding History

Jane Street’s Portfolio EMMA Stock Details EMMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,203	Closed	-$35K	–	6030
2018 Q2	$35K	Buy	+3,203	New	+$42.3K	﹤0.01%	4846

Other funds holding EMMA

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

FFA

First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jane Street's EMMA Position: Q3 2018 in Review

Jane Street sold out of Emmaus Life Sciences, Inc. Common Stock (EMMA) in Q3 2018, closing a stake of 3,203 shares — an estimated $35K sold.

Jane Street first reported a position in EMMA in Q2 2018 and held it in 1 quarter. The position peaked at $35K in Q2 2018. 9 funds tracked by Wall St. Rank hold EMMA as of Q3 2018.

Jane Street reported no remaining Emmaus Life Sciences, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Jane Street sold 3,203 Emmaus Life Sciences, Inc. Common Stock shares in Q3 2018, an estimated $35K.
Jane Street first reported a position in Emmaus Life Sciences, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
Jane Street's Emmaus Life Sciences, Inc. Common Stock position peaked at $35K in Q2 2018.
9 funds tracked by Wall St. Rank held Emmaus Life Sciences, Inc. Common Stock as of Q3 2018.

Based on Jane Street's 13F filing for Q3 2018, filed 14 Nov 2018.